Pramipexole Hydrochloride

  • Pramipexole Hydrochloride 1
  • Pramipexole Hydrochloride 2
  • Pramipexole Hydrochloride 3
Product Description

Pramipexole dihydrochloride is a non-ergot dopamine agonist indicated for the treatment of:

  • Parkinson's disease (PD)

    • Moderate-to-severe primary Restless Legs Syndrome (RLS)

    Read more Show less

    Zennova Pharmaceuticals(Chengdu)Co.,Ltd

    • Country/Region:
      China
    • Founded:
      2018
    • On CPHI since:
      2025
    • Certificates:
      1
    • Employees:
      50 - 99
    Company types
    Biopharmaceutical company
    CMO/CDMO
    Contract Research Organisation (CRO)
    Distributor/Import Export
    Generics/Biosimilars Manufacturer
    Primary activities
    Chemical Development
    Contract Manufacturer
    Contract Research Organisation
    Pharmaceutical Company (generic finished products)
    View company profile
    Categories
    more categories Show less
    Specifications
    • Details
      Restless Legs Syndrome, RLSParkinson's Disease
    • Selling Points
      Experienced Technicians; Prompt Delivery; Sustainability
    • Supplied from
      China
    • Measured In
      US$
    More specifications Fewer specifications
    Sales Markets
    Show more Show less

    Zennova Pharmaceuticals(Chengdu)Co.,Ltd

    • Country/Region:
      China
    • Founded:
      2018
    • On CPHI since:
      2025
    • Certificates:
      1
    • Employees:
      50 - 99
    Company types
    Biopharmaceutical company
    CMO/CDMO
    Contract Research Organisation (CRO)
    Distributor/Import Export
    Generics/Biosimilars Manufacturer
    Primary activities
    Chemical Development
    Contract Manufacturer
    Contract Research Organisation
    Pharmaceutical Company (generic finished products)
    View company profile